Literature DB >> 9148746

Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein.

S L Sierke1, K Cheng, H H Kim, J G Koland.   

Abstract

The putative protein tyrosine kinase domain (TKD) of the ErbB3 (HER3) receptor protein was generated as a histidine-tagged recombinant protein (hisTKD-B3) and characterized enzymologically. CD spectroscopy indicated that the hisTKD-B3 protein assumed a native conformation with a secondary structure similar to that of the epidermal growth factor (EGF) receptor TKD. However, when compared with the EGF receptor-derived protein, hisTKD-B3 exhibited negligible intrinsic protein tyrosine kinase activity. Immune complex kinase assays of full-length ErbB3 proteins also yielded no evidence of catalytic activity. A fluorescence assay previously used to characterize the nucleotide-binding properties of the EGF receptor indicated that the ErbB3 protein was unable to bind nucleotide. The hisTKD-B3 protein was subsequently found to be an excellent substrate for the EGF receptor protein tyrosine kinase, which suggested that in vivo phosphorylation of ErbB3 in response to EGF could be attributed to a direct cross-phosphorylation by the EGF receptor protein tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9148746      PMCID: PMC1218252          DOI: 10.1042/bj3220757

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Autophosphorylation activates the soluble cytoplasmic domain of the insulin receptor in an intermolecular reaction.

Authors:  M H Cobb; B C Sang; R Gonzalez; E Goldsmith; L Ellis
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

3.  Synthesis of epidermal growth factor (EGF) receptor in vitro using SP6 RNA polymerase-transcribed template mRNA.

Authors:  A J Clark; L Beguinot; S Ishii; D P Ma; B A Roe; G T Merlino; I Pastan
Journal:  Biochim Biophys Acta       Date:  1986-08-22

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Detection and purification of a recombinant human B lymphotropic virus (HHV-6) in the baculovirus expression system by limiting dilution and DNA dot-blot hybridization.

Authors:  M C Fung; K Y Chiu; T Weber; T W Chang; N T Chang
Journal:  J Virol Methods       Date:  1988-01       Impact factor: 2.014

6.  Expression of epidermal growth factor receptor sequences as E. coli fusion proteins: applications in the study of tyrosine kinase function.

Authors:  J G Koland; K M O'Brien; R A Cerione
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

7.  Activation of the EGF receptor tyrosine kinase by divalent metal ions: comparison of holoreceptor and isolated kinase domain properties.

Authors:  J G Koland; R A Cerione
Journal:  Biochim Biophys Acta       Date:  1990-05-22

8.  Activation of the purified protein tyrosine kinase domain of the epidermal growth factor receptor.

Authors:  P B Wedegaertner; G N Gill
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

9.  Synthesis, purification, and characterization of the cytoplasmic domain of the human insulin receptor using a baculovirus expression system.

Authors:  R Herrera; D Lebwohl; A Garcia de Herreros; R G Kallen; O M Rosen
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

10.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.

Authors:  M H Kraus; W Issing; T Miki; N C Popescu; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more
  74 in total

Review 1.  Evolution of signal transduction by gene and genome duplication in fish.

Authors:  Jean-Nicolas Volff; Manfred Schartl
Journal:  J Struct Funct Genomics       Date:  2003

2.  ERBB3: Multifunctional enabler or primary actor in pancreatic cancer?

Authors:  Ralf Landgraf
Journal:  Cancer Biol Ther       Date:  2010-09-13       Impact factor: 4.742

3.  Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma.

Authors:  Chunrong Li; Toni M Brand; Mari Iida; Shyhmin Huang; Eric A Armstrong; Albert van der Kogel; Deric L Wheeler
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

4.  HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy.

Authors:  Marcia R Campbell; Dhara Amin; Mark M Moasser
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

5.  erbB3 is an active tyrosine kinase capable of homo- and heterointeractions.

Authors:  Mara P Steinkamp; Shalini T Low-Nam; Shujie Yang; Keith A Lidke; Diane S Lidke; Bridget S Wilson
Journal:  Mol Cell Biol       Date:  2013-12-30       Impact factor: 4.272

6.  Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.

Authors:  Abhik Bandyopadhyay; Edward Favours; Doris A Phelps; Vanessa Del Pozo; Samson Ghilu; Dias Kurmashev; Joel Michalek; Aron Trevino; Denis Guttridge; Cheryl London; Kenji Hirotani; Ling Zhang; Raushan T Kurmasheva; Peter J Houghton
Journal:  Pediatr Blood Cancer       Date:  2017-10-28       Impact factor: 3.167

Review 7.  Drug Resistance to EGFR Inhibitors in Lung Cancer.

Authors:  Osamu Tetsu; Matthew J Hangauer; Janyaporn Phuchareon; David W Eisele; Frank McCormick
Journal:  Chemotherapy       Date:  2016-02-25       Impact factor: 2.544

8.  Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.

Authors:  Natalia Jura; Yibing Shan; Xiaoxian Cao; David E Shaw; John Kuriyan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

Review 9.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

10.  Geldanamycin selectively targets the nascent form of ERBB3 for degradation.

Authors:  Candice S Gerbin; Ralf Landgraf
Journal:  Cell Stress Chaperones       Date:  2010-01-19       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.